• Return to Headlines

Pdl Biopharma In is Among the Companies in the Biotechnology Industry With the Lowest EBITDA Growth (PDLI, UTHR, GILD, MYGN, AMGN)

By David Diaz

Below are the three companies in the Biotechnology industry with the lowest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Pdl Biopharma In ranks lowest with a EBITDA growth of -63.9%. Following is United Therapeut with a EBITDA growth of -37.2%. Gilead Sciences ranks third lowest with a EBITDA growth of -13.7%.

Myriad Genetics follows with a EBITDA growth of -12.2%, and Amgen Inc rounds out the bottom five with a EBITDA growth of 6.6%.

SmarTrend is tracking the current trend status for Pdl Biopharma In and will alert subscribers who have PDLI in their portfolio or watchlist when shares have changed trend direction.

Keywords: lowest ebitda growth pdl biopharma in united therapeut Gilead Sciences myriad genetics amgen inc

Ticker(s): PDLI UTHR GILD MYGN AMGN